NCT05717140 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05717140
Title	Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung
Recruitment	Withdrawn
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Mayo Clinic
Indications	melanoma
Therapies	Nivolumab + Sargramostim
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Mayo Clinic in Rochester		Rochester	Minnesota	55905	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05717140Clinical Trial Detail